New hope for elderly myeloma patients: immune therapy trial targets tough relapses
Disease control
Recruiting now
This study is testing a new immune therapy called talquetamab in elderly patients whose multiple myeloma has returned after prior treatments. Talquetamab is an injection that helps the patient's own immune cells find and attack the cancer. If the cancer progresses on talquetamab …
Phase: PHASE2 • Sponsor: Larysa Sanchez • Aim: Disease control
Last updated Mar 30, 2026 14:30 UTC